[ Price : $8.95]
FDA issues Regeneron a second complete response letter on its BLA for odronextamab and its use in relapsed/refractory follicular l...[ Price : $8.95]
Allogene Therapeutics modifies its ALPHA3 clinical trial for large B-cell lymphoma following the death of a patient attributed to ...[ Price : $8.95]
FDA approves LENZ Therapeutics Vizz (aceclidine ophthalmic solution) 1.44% for treating presbyopia, a common age-related condition...[ Price : $8.95]
Illumina agrees to pay $9.8 million to settle allegations that it violated the False Claims Act by selling genomic sequencing syst...[ Price : $8.95]
Draeger recalls (Class 1) its SafeStar 90 Plus bidirectional breathing system filter after receiving reports of slow increase of C...[ Price : $8.95]
Hamilton Medical recalls (Class 1) its coaxial (1.8 m) breathing circuit set with flow sensor and expiratory valve that are used w...[ Price : $8.95]
Eli Lilly reports favorable data from the SURPASS-CVOT trial that showed its diabetes drug Mounjaro (tirzepatide) matched the card...[ Price : $8.95]
FDA approves SetPoint Medicals SetPoint System, a novel neurostimulation device to treat some rheumatoid arthritis patients.